PIK3CA mutation fortifies molecular determinants for immune signaling in vascular cancers

D Lee, EC Kozurek, M Abdullah, EJ Wong, R Li… - Cancer gene …, 2024 - nature.com
Angiosarcomas are a group of vascular cancers that form malignant blood vessels. These
malignancies are seemingly inflamed primarily due to their pathognomonic nature, which …

A Population-Based Long-Term Follow-Up of Soft Tissue Angiosarcomas: Characteristics, Treatment Outcomes, and Prognostic Factors

CE Holm, M Ørholt, ML Talman, K Abebe, A Thorn… - Cancers, 2024 - mdpi.com
Simple Summary Angiosarcoma is a rare type of soft tissue sarcoma with a progressive and
unpredictable disease course. Currently, surgery is the only well-defined treatment option …

[HTML][HTML] WGCNA and Integrative Network Analysis identify CHRNA5 and CTLA4 as potential therapeutic targets against Angiosarcoma

T Bhatnagar, M Haider, Y Khan, MZ Ashraf - Cancer Treatment and …, 2025 - Elsevier
Angiosarcomas are a type of soft-tissue sarcoma characterized by aggressive malignant
tumors originating from endothelial cells of blood vessels or lymphatic vessels. Limited …

[HTML][HTML] Analysis of risk factors affecting the prognosis of angiosarcoma patients: a retrospective study

Y Li, L Tian, D Sun - American Journal of Cancer Research, 2024 - pmc.ncbi.nlm.nih.gov
This study aimed to identify prognostic factors influencing the survival of angiosarcoma
patients and to explore the relationship between peripheral blood indicators and patient …

[HTML][HTML] Optimizing strategies for lymphaticovenular anastomosis in lower secondary extremity lymphedema

L Yi, YF Jiang, L Xu, M Zheng, Y Zheng, J Liang… - Journal of Vascular …, 2025 - Elsevier
Background Lymphovenous anastomosis (LVA) has become an increasingly common
treatment for patients with secondary extremity lymphedema. The objective of this study was …

Genomic landscape and preclinical models of angiosarcoma

A Benton, B Liu, LE Gartenhaus, JA Hanna - Molecular Oncology - Wiley Online Library
Angiosarcoma is a cancer that develops in blood or lymphatic vessels that presents a
significant clinical challenge due to its rarity and aggressive features. Clinical outcomes …